MMJ Group Holdings Limited (ASX: MMJ) ("MMJ") is pleased to note the attached announcement by Harvest One Cannabis Inc. (TSX V:HVT) (OTCQX: HRVOF) ("Harvest One") confirming that it has launched European sales of its recently reformulated Satipharm CBD capsules.
MMJ owns 55,557,994 shares in Harvest One for a 30.5% shareholding.
For more information, download the attached PDF.
Download this document
